-
Global Biopharma Layoffs March 2026
Layoffs
Global Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Global Biopharma Layoffs November 2025
Layoffs
This article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
-
Bayer $1.3 Billion Collaboration Agreement
Bayer
Bayer and Kumquat Biosciences announce a $1.3 billion global collaboration to develop and commercialize a KRAS G12D inhibitor, aiming to offer new treatment options for pancreatic, colorectal, and lung cancer patients.
-
-
-
-
-
Bayer's 2024 Financial report
Financial statements
Bayer's 2024 financial report reveals a 2.2% revenue decline, 6,908 job cuts, and ongoing legal battles. With strategic shifts and heavy R&D investment, the company faces challenges and opportunities ahead. Can Bayer turn the tide by 2025?
-
-
衡东县|
化州市|
大宁县|
夏河县|
盐亭县|
昆山市|
瓮安县|
射阳县|
萨嘎县|
绥棱县|
平塘县|
高尔夫|
宜州市|
额敏县|
宁安市|
沈丘县|
麻江县|
司法|
仙居县|
松潘县|
呼图壁县|
德化县|
应城市|
安岳县|
延长县|
油尖旺区|
遂平县|
津市市|
元阳县|
琼中|
西城区|
霍州市|
东光县|
阿尔山市|
连云港市|
阳朔县|
崇左市|
城口县|
越西县|
花垣县|
莱芜市|